case report aspiration glp-1 receptor agonist anesthesia 2023 Perioperative Use of Agonists in Patients Undergoing Cardiac Procedures: A Scoping Review Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists:

These drugs have potent glucose-lowering actions and, additionally, lower body weight through satiety induction while reducing blood pressure and dyslipidemia

Other oral compounds like CT-996 / RG 6652 showed a clinically meaningful weight reduction of 6-7% in four weeks among participants without T2D, and GSBR-1290 has demonstrated favourable safety, tolerability and efficacy results

Discover if Zepbound is the right treatment for you.

We also present practical implications of these glucose-lowering agents for reducing the risk of adverse cardiovascular events and progressive renal comorbidity in patients with T2D and CVD.

See if you qualify